Pure Global
NCT06359483

The Impact of Meal Frequency on Bone Remodeling in Healthy Adults

A Randomized Controlled Pilot Study on the Short-Term Impact of Meal Frequency on Bone Remodeling in Healthy Adults
University of Jordan·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Healthy Adults
Drug/Device/Intervention
Meal Frequency Manipulation
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
University of Jordan
Location
Amman, Jordan
Timeline & enrollment
Phase
N/A
Start date
Jun 19, 2021
End date
Jul 04, 2021
Enrollment
30 participants
Primary outcome

The title of the primary outcome is Procollagen Type 1 N-terminal propeptide (P1NP) Levels.

Summary

The study aimed to investigate the effect of meal frequency on bone remodeling using the
 marker Procollagen Type 1 N-terminal propeptide (P1NP). Thirty healthy adult males from
 Jordan participated in a randomized controlled intervention trial. They were randomly
 assigned to three or eight daily meals for three consecutive days over two phases. Blood
 samples were obtained at the beginning and end of each phase, and P1NP levels were analyzed.
 The results showed a substantial drop in P1NP levels compared to the baseline, indicating
 that meal frequency influences bone development. There were no significant changes between
 the groups eating three and eight meals per day. The study emphasizes the importance of
 dietary patterns in bone health and advises additional research to understand the
 relationship between meal frequency and bone metabolism.

ICD-10 classifications
ObesityHealthy person accompanying sick personObesity, unspecifiedRoutine general health check-up of inhabitants of institutionsLifestyle-related condition
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06359483
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06359483 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Jordan and is currently Completed. The study focuses on Healthy Adults. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.